Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Exercise training in CKD: efficacy, adherence, and safety
Howden EJ, Coombes JS, Strand H, Douglas B, Campbell KL, Isbel NM
American Journal of Kidney Diseases 2015 Apr;65(4):583-591
clinical trial
5/10 [Eligibility criteria: No; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

BACKGROUND Exercise training increasingly is recommended as an important part of the management of cardiovascular disease. However, few studies have evaluated the effectiveness of exercise training in patients with chronic kidney disease (CKD), and those that have included very selective populations. STUDY DESIGN Analysis of secondary outcomes of a randomized controlled trial, with participants randomly assigned to either lifestyle intervention or usual care (control). SETTING AND PARTICIPANTS Patients with CKD stages 3 to 4 and one or more uncontrolled cardiovascular risk factor were recruited from an outpatient clinic at a large tertiary hospital. Intervention Lifestyle intervention included access to multidisciplinary care through a nurse practitioner-led CKD clinic, exercise training, and a lifestyle program. The exercise training was a 2-phased program in which participants received 8 weeks of supervised training before commencing 10 months of home-based training. OUTCOMES AND MEASUREMENTS Efficacy, as assessed by metabolic equivalent tasks (METs), 6-minute walk distance, Timed Get-Up-and-Go test, grip strength, and anthropomorphic measures; adherence, as assessed by self-reported physical activity; and safety, as assessed by reported serious adverse events, were recorded. RESULTS 83 patients were randomly assigned and 72 patients completed follow-up testing (intervention n = 36; control n = 36). The intervention resulted in a significant improvement in METs (pre 7.2 +/- 3.3; post 9.7 +/- 3.6), 6-minute walk distance (pre 485 +/- 110 m; post 539 +/- 82 m), and body mass index (pre 32.5 +/- 6.7 kg/m2; post 31.9 +/- 7.3 kg/m2). Reported physical activity levels significantly increased in the intervention group at 6 months, but decreased at 12 months. There were no serious adverse events related to the exercise training. Limitations This study was not powered to evaluate the safety of exercise training on serious adverse events. CONCLUSIONS The findings from the present study suggest that an exercise program that includes a supervised and home-based training phase is effective, adhered to, and safe in patients with CKD.
With permission from the National Kidney Foundation.

Full text (sometimes free) may be available at these link(s):      help